Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Welte

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
Blood|November 11, 2010
PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cellsWolfgang Koestner, Martin Hapke, Jessica Herbst, et al.
Nature Medicine|October 26, 2006
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropeniaJulia Skokowa, Gunnar Cario, Murat Uenalan, et al.
Blood|September 25, 2004
Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemiaGunnar Cario, Martin Stanulla, Bernard M Fine, et al.
Blood Advances|January 4, 2018
Gene correction of <i>HAX1</i> reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cellsErik Pittermann, Nico Lachmann, Glenn MacLean, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2006
Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95André Schrauder, Alfred Reiter, Helmut Gadner, et al.
The Journal of Allergy and Clinical Immunology|September 10, 2013
High-content cytometry and transcriptomic biomarker profiling of human B-cell activationChristian Hennig, Claudia Ilginus, Kaan Boztug, et al.
Experimental Hematology|August 11, 2022
Corrigendum to 'Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation' <[Experimental Hematology, Volume 71, 2019;71:51-60]>Benjamin Dannenmann, Azadeh Zahabi, Perihan Mir, et al.
JAMA|March 24, 2005
Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemiaMartin Stanulla, Elke Schaeffeler, Thomas Flohr, et al.
Blood|March 16, 2006
Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2Johannes Jung, Georg Bohn, Anna Allroth, et al.
Experimental Hematology|January 8, 2019
Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34<sup>+</sup> cells preceding leukemic transformationBenjamin Dannenmann, Azadeh Zahabi, Perihan Mir, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
Blood|November 11, 2010
PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cellsWolfgang Koestner, Martin Hapke, Jessica Herbst, et al.
Nature Medicine|October 26, 2006
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropeniaJulia Skokowa, Gunnar Cario, Murat Uenalan, et al.
Blood|September 25, 2004
Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemiaGunnar Cario, Martin Stanulla, Bernard M Fine, et al.
Blood Advances|January 4, 2018
Gene correction of <i>HAX1</i> reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cellsErik Pittermann, Nico Lachmann, Glenn MacLean, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2006
Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95André Schrauder, Alfred Reiter, Helmut Gadner, et al.
The Journal of Allergy and Clinical Immunology|September 10, 2013
High-content cytometry and transcriptomic biomarker profiling of human B-cell activationChristian Hennig, Claudia Ilginus, Kaan Boztug, et al.
Experimental Hematology|August 11, 2022
Corrigendum to 'Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation' <[Experimental Hematology, Volume 71, 2019;71:51-60]>Benjamin Dannenmann, Azadeh Zahabi, Perihan Mir, et al.
JAMA|March 24, 2005
Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemiaMartin Stanulla, Elke Schaeffeler, Thomas Flohr, et al.
Blood|March 16, 2006
Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2Johannes Jung, Georg Bohn, Anna Allroth, et al.
Experimental Hematology|January 8, 2019
Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34<sup>+</sup> cells preceding leukemic transformationBenjamin Dannenmann, Azadeh Zahabi, Perihan Mir, et al.
Pageof 15